Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06541145 · ClinicalTrials.gov registry record · NA
Bacterial Decolonization Within Dyads
A NA study of Bacterial Colonization, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06541145 is a NA study of Bacterial Colonization that is actively recruiting participants, run by Duke University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06541145, a NA study of Bacterial Colonization, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to measure bacterial burden, specifically Staph aureus, and how it spreads between mothers and their infants. Researchers will evaluate if the amount of bacteria on their skin remains the same after mothers use a skin antisepsis treatment prior to delivering their infants. The investigators also aim to assess participant interest in and compliance with skin antisepsis treatments. The hypothesis is that increased maternal interest will align with increased treatment compliance.
Conditions Studied
Interventions
- DRUG Mupirocin
- DRUG Chlorhexidine baths
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-08-21 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06541145
The ClinicalTrials.gov registry entry for NCT06541145 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Colonization appearing as the primary indexed condition, and to 2 interventions - of which Mupirocin is the first listed.
NCT06541145 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06541145 about?
NCT06541145 is a clinical study titled "Bacterial Decolonization Within Dyads". The goal of this study is to measure bacterial burden, specifically Staph aureus, and how it spreads between mothers and their infants. Researchers will evaluate if the amount of bacteria on their skin remains the same after mothers use a skin antisepsis treatment prior to delivering their infants. ...
What is the current status of trial NCT06541145?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-08-21. Estimated completion is 2026-06.
What conditions does trial NCT06541145 study?
This clinical trial studies the following conditions: Bacterial Colonization.
What interventions are being tested in trial NCT06541145?
The interventions under investigation include: Mupirocin (DRUG), Chlorhexidine baths (DRUG).
Who is sponsoring clinical trial NCT06541145?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06541145 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.